Despite substantial declines in the numbers of reported cases in recent years, gonorrhea remains the most commonly reported bacterial infection in the United States. In 1992, 501,409 cases of gonorrhea were reported to the Public Health Service, a figure which may underestimate the true numbers of cases by as much as 50% (4) . Signs and symptoms of gonococcal infections in women are nonspecific, and a substantial proportion of women with proven infections are asymptomatic (6) . Nonetheless, complications and sequelae of gonococcal infections are most severe for women. These include pelvic inflammatory disease, infertility, and ectopic pregnancy. Thus, screening for gonococcal infection remains a public health priority.
Detection by culture of Neisseria gonorrhoeae in women, although relatively inexpensive and highly sensitive, is logistically complex, requiring patients to undergo pelvic examination with a speculum for specimen collection. This constraint may act as a disincentive for patients to seek screening and serve to limit testing to environments equipped for performing pelvic examinations. In addition, screening for gonorrhea with single cervical swab cultures is not 100% sensitive, because of multiple factors which include sampling errors, inhibition of growth by components of selective culture media, and loss of viability during specimen transport (2, 5, 6, 11) . The high degree of sensitivity of nucleic acid amplification tests for microbiologic diagnosis and recent studies demonstrating the utility of ligase chain reaction (LCR) testing of both urine and swab specimens for the sensitive and specific diagnosis of Chlamydia trachomatis infections suggested to us that urine might serve as an appropriate substitute for swab specimens in LCR testing for the diagnosis of gonorrhea in women (3, 8, 19 ). We evaluated the potential utility of a gap LCR assay developed by Abbott Laboratories for gonorrhea screening in women, focusing on the testing of first-void urine specimens.
MATERIALS AND METHODS
Specimen collection and processing. Two hundred and eighty-three women attending the Jefferson County Department of Health STD Clinic in Birmingham, Alabama, were evaluated for gonorrhea infection in a study approved by the Institutional Review Board for Human Subjects of the University of Alabama at Birmingham. The only exclusion criteria for participation in the study were the use of antimicrobial agents active against N. gonorrhoeae in the preceding 14 days, the inability to provide a urine specimen, or refusal to participate in the study. Separate cervical and urethral swab specimens were obtained from each participant. The swabs were used to directly inoculate modified Thayer-Martin media for N. gonorrhoeae culture at the time of specimen collection (see below); following inoculation of the culture media, the swabs were placed into separate, labeled snap-top tubes containing 0.6 ml of buffer for LCR testing. After the cultures were obtained, the patients were asked to collect the initial approximately 30 ml of a first-void urine specimen into marked plastic specimen cups for subsequent LCR testing. Following inoculation, the gonorrhea cultures were placed in a 5%-CO 2 environment and incubated at 35ЊC until they were transported to the laboratory, where incubation was continued until the plates were read. All specimens for possible LCR testing (two swab tubes and one urine container per patient) were kept at 4ЊC for less than 18 h until transported to the laboratory, where swabs were frozen at Ϫ70ЊC in transport buffer, and 10-ml aliquots of unspun urine were pipetted into polyethylene tubes and also frozen at Ϫ70ЊC until LCR testing.
On the day of LCR testing, urine samples were thawed and vortexed and a 1-ml aliquot was transferred to a labelled microcentrifuge tube. The samples were centrifuged for 10 min at 13,000 rpm (Micro Centrifuge Model 235C). The urine supernatant was then removed by pipet, and 1 ml of urine LCR resuspension buffer was added to each tube. The microcentrifuge tubes were sealed with lid locks and vortexed to resuspend the pellet. The samples were then placed in a dry bath at 95 to 100ЊC for 12 to 16 min to lyse the cells and stored at 4ЊC until processing with a thermal cycler. Similarly, the swab specimens which were used to resolve discrepant results (see below) were thawed on the day of processing and then heated in a dry bath at 95 to 100ЊC for 14 to 16 min. After being cooled to room temperature, these samples were ready for thermal-cycler processing.
Culture methods. The specimens for N. gonorrhoeae culture were obtained by using dacron-tipped swabs provided as part of the LCR specimen collection kit and were directly inoculated onto modified Thayer-Martin media. The cultures were examined following overnight incubation, and if negative on initial evaluation, they were examined again following an additional 24 and 48 h of incubation. Typical colonies containing gram-negative diplococci and giving a positive oxidase reaction were presumptively identified as N. gonorrhoeae. The identities of presumptive N. gonorrhoeae organisms were confirmed by using fluoresceinconjugated monoclonal antibodies (Syva Corp., Palo Alto, Calif.) (7) .
DNA amplification. For each DNA amplification that was run, 12 controls provided by the manufacturer and up to 36 different patient samples were prepared by investigators blinded to the results of the gonorrhea culture. Prior to testing, reaction tubes containing the manufacturer's 100-l aliquots of DNA amplification reagents (unit dose tubes) were warmed to room temperature. The reaction mixture included four oligonucleotide probes, DNA polymerase, and a thermostable ligase, which acts to fill in and join adjacent oligonucleotide primers that line up on complementary target DNA, allowing the reaction to commence.
For testing, controls (positive, negative, and calibration) were prepared by adding a magnesium activator. Following vortexing, 100-l volumes of each patient sample and of each control were transferred to the appropriately labeled unit dose tubes. The samples were then immediately placed into the thermal cycler to run for 40 cycles over a 2-h period. Each cycle consisted of the following temperatures and durations: 97ЊC for 1 s, 55ЊC for 1 s, and 62ЊC for 50 s. The initial heating separated the double-stranded DNA into single strands. Then, as the temperature was lowered, if target DNA was present, hybridization of two complementary primers to single strands of target (N. gonorrhoeae) DNA occurred. Subsequently, ligase would join the two nucleotide primers which had hybridized to complementary target DNA to form a new primer which would then generate a new full-length oligonucleotide, termed an amplicon. Amplification occurred as reheating during each cycle caused the separation of newly generated amplicons from the target nucleotide, so that when the temperature was lowered again, both the original target and the newly formed amplicons could serve as targets for additional primers to hybridize to and ligate. Hence, with each heating and cooling cycle the number of amplicons for detection increased by nearly twofold. After 40 amplification cycles, the samples were held at 4ЊC prior to testing for the detection of amplicons.
Following thermal-cycle amplification, the samples were brought to room temperature and then pulse-centrifuged at 9,000 ϫ g briefly to eliminate condensation droplets around the caps. One hundred microliters of each sample was transferred to separate LCx reaction cells for amplicon detection. Each transfer was completed prior to opening the top of the next sample for transfer to the LCx reaction cells. Amplicon detection was performed by a microparticle enzyme immunoassay by using LCx instrumentation to detect a fluorescent reaction. Amplicons containing hapten-labelled ligated probes were captured by antibodycoated microparticles, held by a filter. The addition of substrate to the conjugate enzyme catalyzed a fluorescent reaction which was detected by the LCx and recorded as a numerical value. Eighteen patient samples and six controls were included in each LCx run. The controls were included with each LCx run to ensure that they were within expected limits. The patient samples which were recorded as positive had values equal to or greater than 0.25 times the average of the two calibration samples for that run.
Resolution of culture-LCR discrepancies. For patients whose urethral or cervical culture results failed to agree with the results of LCR testing, efforts to resolve discrepancies were carried out as follows. For culture-positive, urine LCR-negative specimens, the LCR assay of urine was repeated. If repeat testing of urine was negative, the urethral and cervical swabs used for the inoculation of culture media were then tested by using the LCR procedure. If one or both swab specimens were positive by LCR, the urine LCR result was considered to be a false negative. For culture-negative, urine LCR-positive specimens, repeat LCR testing of an aliquot of urine using nucleotide primers specific for other targets (protein 1 and pilin) was performed on samples sent to Abbott Laboratories. If a specimen was still positive by LCR, the LCR specimen was considered to be a true positive (i.e., the culture was a false negative).
RESULTS

Patient population.
The 283 women participating in this study were typical of women attending the Jefferson County Department of Health STD Clinic. The median age of study participants was 27 (range, 13 to 65) years. Two hundred and sixty (91.9%) participants were African-American. The remaining 23 participants were Caucasian. Urogenital cultures from 54 (19.1%) of the 283 participants were culture positive for N. gonorrhoeae. In 41 (76%) culture-positive women, both cervical and urethral cultures were positive. In an additional 12 (22%) and 1 (2%) culture-positive women, only the cervical and urethral cultures, respectively, were positive (Fig. 1) .
Results of LCR testing. The initial results of the urine LCR testing are compared with the results of the cervical and urethral cultures in Table 1 . In 278 (98.2%) of 283 women, the results of urine LCR testing corresponded to the results of the cervical or urethral cultures for N. gonorrhoeae. For the remaining five patients, discrepancies were noted. For three patients, cultures obtained from the uterine cervix or urethra were positive for N. gonorrhoeae, while urine LCR results were negative. To further evaluate the accuracy of the culture results and to evaluate whether LCR would fail to detect the gonococci infecting these patients, LCR was performed on the swabs used to inoculate the culture plates. In each of these three cases, the results of culture were confirmed by a positive LCR result with the swabs used to inoculate the culture plates; thus, these three specimens represented false-negative urine LCR results. For two other specimens, urine LCR assays were positive while cultures obtained from the cervix and urethra were negative. The results of LCR testing of the swabs used to inoculate the culture plates for each of these patients were also negative. In addition, repeat LCR testing of these urine specimens was performed by using two additional primer sets unrelated to the initial LCR primer set. Both of these specimens were LCR positive, and thus the culture results were classified as false-negatives.
Following the resolution of the discrepant results as noted above, the sensitivity, specificity, and positive and negative predictive values of LCR for the detection of gonorrhea in urine specimens were 94.6, 100, 100, and 98.7%, respectively. 
a Culture-LCR discrepancies; see the text.
DISCUSSION
In this study, LCR testing of first-void, non-clean-catch urine specimens from women attending an STD clinic proved to be highly sensitive and specific for the detection of gonorrhea. To more accurately diagnose infections present in this study population, cultures of both the urethra and cervix were performed. This evaluation revealed that urethral coinfection was common in 41 (77%) of 53 women with culture-proven cervical gonorrhea. In contrast, only one woman had a positive urethral culture for N. gonorrhoeae and a negative cervical culture. Thus, this study validates prior studies which demonstrated that urethral coinfection occurs in 70 to 90% of women with gonorrhea while isolated urethral gonococcal infection is rare (1, 10, 12) . Interestingly, the presence of urethral gonococcal infection was not required for urine LCR testing to accurately diagnose gonorrhea infection in these patients. Among 12 women in this study with positive cervical but negative urethral cultures for N. gonorrhoeae, urine LCR testing detected infection in 11 (92%) of them. It is possible that some of these patients may have had urethral infections which were not detected by culture. Alternatively, in these women urine LCR may have been positive as a consequence of the contamination of urine specimens by infected cervical-vaginal secretions. On the basis of earlier studies evaluating the sensitivity of LCR testing of cervical and urethral swab specimens for the detection of gonococcal infections (unpublished data), we believe that the former hypothesis explains at best the results for only a small proportion of infected patients.
In this study, had only cervical cultures for N. gonorrhoeae been performed, as is usually the case in clinical screening situations, 53 of 54 culture-positive infections would have been detected and infections in two patients whose cultures were negative would have been missed (54 [96.4%] of all 56 proven infections diagnosed). In comparison, urine LCR testing detected 51 of 54 culture-proven gonococcal infections as well as infections in two specimens from women who appeared to be infected but who had negative cultures (53 [94.6%] of 56 infections). Thus, when compared with more typical screening practices, urine LCR testing and culture screening with cervical swab specimens have essentially equivalent performance characteristics for the detection of N. gonorrhoeae.
In many settings where culture screening for gonorrhea is currently performed on a routine basis, because of cost and logistical considerations urine testing for the detection of gonorrhea may not represent a major clinical advantage. In contrast, in settings where the performance of pelvic examinations is difficult or in settings where transport conditions may lead to reduced sensitivity of cultures, urine testing has potential advantages. Thus, these data complement recent data suggesting that testing of urine specimens for C. trachomatis by LCR or PCR may be as sensitive as, or even more sensitive than, the usual cell culture for the detection of chlamydial infection. For settings such as school-based clinics, detention centers, or other locations where transport or logistical problems compromise the ability to screen women for STDs, urine LCR testing also provides the possibility of testing for two major STD pathogens in women by using a single urine specimen. Thus, the high degree of sensitivity of LCR for the detection of N. gonorrhoeae extends the capacity to expand STD screening to populations for which more traditional diagnostic testing strategies are not currently accessible. If the impressive performance of LCR testing for the diagnosis of gonorrhea is validated by further studies conducted in low-as well as highprevalence settings, an evaluation of the ways in which the test can be used to cost effectively augment current gonorrhea control efforts is warranted. On the basis of our data, LCR performed on urine specimens for the detection of N. gonorrhoeae in women represents a highly sensitive, specific, and logistically simple mechanism for screening for gonococcal infections in women.
